Author: Brian T. Yeh
Publisher: DIANE Publishing
ISBN: 1437941680
Category : Chemicals
Languages : en
Pages : 18
Book Description
Legal Issues Relating to the Disposal of Dispensed Controlled Substances
Author: Brian T. Yeh
Publisher: DIANE Publishing
ISBN: 1437941680
Category : Chemicals
Languages : en
Pages : 18
Book Description
Publisher: DIANE Publishing
ISBN: 1437941680
Category : Chemicals
Languages : en
Pages : 18
Book Description
Legal Issues Relating to the Disposal of Dispensed Controlled Substances
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Drug Waste and Disposal
Author: United States. Congress. Senate. Special Committee on Aging
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 100
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 100
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Disposal of Controlled Substances (Us Drug Enforcement Administration Regulation) (Dea) (2018 Edition)
Author: The Law The Law Library
Publisher: Createspace Independent Publishing Platform
ISBN: 9781722238070
Category :
Languages : en
Pages : 110
Book Description
Disposal of Controlled Substances (US Drug Enforcement Administration Regulation) (DEA) (2018 Edition) The Law Library presents the complete text of the Disposal of Controlled Substances (US Drug Enforcement Administration Regulation) (DEA) (2018 Edition). Updated as of May 29, 2018 This rule governs the secure disposal of controlled substances by registrants and ultimate users. These regulations will implement the Secure and Responsible Drug Disposal Act of 2010 by expanding the options available to collect controlled substances from ultimate users for the purpose of disposal, including: Take-back events, mail-back programs, and collection receptacle locations. These regulations contain specific language allowing law enforcement to voluntarily continue to conduct take-back events, administer mail-back programs, and maintain collection receptacles. These regulations will allow authorized manufacturers, distributors, reverse distributors, narcotic treatment programs (NTPs), hospitals/clinics with an on-site pharmacy, and retail pharmacies to voluntarily administer mail-back programs and maintain collection receptacles. In addition, this rule expands the authority of authorized hospitals/clinics and retail pharmacies to voluntarily maintain collection receptacles at long-term care facilities. This rule also reorganizes and consolidates previously existing regulations on disposal, including the role of reverse distributors. This book contains: - The complete text of the Disposal of Controlled Substances (US Drug Enforcement Administration Regulation) (DEA) (2018 Edition) - A table of contents with the page number of each section
Publisher: Createspace Independent Publishing Platform
ISBN: 9781722238070
Category :
Languages : en
Pages : 110
Book Description
Disposal of Controlled Substances (US Drug Enforcement Administration Regulation) (DEA) (2018 Edition) The Law Library presents the complete text of the Disposal of Controlled Substances (US Drug Enforcement Administration Regulation) (DEA) (2018 Edition). Updated as of May 29, 2018 This rule governs the secure disposal of controlled substances by registrants and ultimate users. These regulations will implement the Secure and Responsible Drug Disposal Act of 2010 by expanding the options available to collect controlled substances from ultimate users for the purpose of disposal, including: Take-back events, mail-back programs, and collection receptacle locations. These regulations contain specific language allowing law enforcement to voluntarily continue to conduct take-back events, administer mail-back programs, and maintain collection receptacles. These regulations will allow authorized manufacturers, distributors, reverse distributors, narcotic treatment programs (NTPs), hospitals/clinics with an on-site pharmacy, and retail pharmacies to voluntarily administer mail-back programs and maintain collection receptacles. In addition, this rule expands the authority of authorized hospitals/clinics and retail pharmacies to voluntarily maintain collection receptacles at long-term care facilities. This rule also reorganizes and consolidates previously existing regulations on disposal, including the role of reverse distributors. This book contains: - The complete text of the Disposal of Controlled Substances (US Drug Enforcement Administration Regulation) (DEA) (2018 Edition) - A table of contents with the page number of each section
Pain Modulation
Author: Howard L. Fields
Publisher: Elsevier Publishing Company
ISBN: 9780444809841
Category : Medical
Languages : en
Pages : 454
Book Description
This volume represents edited material that was presented at a conference on brainstem modulation of spinal nociception held in Beaune, France during July, 1987. Pain Modulation, Volume 77 in the series Progress in Brain Research reviews, analyses and suggests new research strategies on several relevant topics including: the endogenous opioid peptides; sites of action of opiates; the role of biogenic animes and non-opioid peptides in analgesia; dorsal horn circuitry; behavioural factors in the activation of pain modulating networks and clinical studies of nociceptive modulation.
Publisher: Elsevier Publishing Company
ISBN: 9780444809841
Category : Medical
Languages : en
Pages : 454
Book Description
This volume represents edited material that was presented at a conference on brainstem modulation of spinal nociception held in Beaune, France during July, 1987. Pain Modulation, Volume 77 in the series Progress in Brain Research reviews, analyses and suggests new research strategies on several relevant topics including: the endogenous opioid peptides; sites of action of opiates; the role of biogenic animes and non-opioid peptides in analgesia; dorsal horn circuitry; behavioural factors in the activation of pain modulating networks and clinical studies of nociceptive modulation.
Dealing with Drugs Control, Prevention, and Treatment
Author: Courtney M. Blanchard
Publisher:
ISBN: 9781612093499
Category : Drug control
Languages : en
Pages : 0
Book Description
Federal domestic drug control policy has evolved over the course of the past century and currently consists of a three-pronged approach to reducing illegal drug use: prevention, substance abuse treatment and enforcement activities. This book examines the war on drugs and drug enforcement efforts; the National Youth Anti-Drug Media Campaign; the background and effectiveness of the drug courts and the legal issues relating to the disposal of dispensed controlled substances.
Publisher:
ISBN: 9781612093499
Category : Drug control
Languages : en
Pages : 0
Book Description
Federal domestic drug control policy has evolved over the course of the past century and currently consists of a three-pronged approach to reducing illegal drug use: prevention, substance abuse treatment and enforcement activities. This book examines the war on drugs and drug enforcement efforts; the National Youth Anti-Drug Media Campaign; the background and effectiveness of the drug courts and the legal issues relating to the disposal of dispensed controlled substances.
The Controlled Substances Act
Author: Brian T. Yeh
Publisher:
ISBN: 9781457842368
Category :
Languages : en
Pages : 20
Book Description
This report highlights certain non-criminal regulatory requirements of the Controlled Substances Act (CSA). The CSA and its implementing regulations establish a framework through which the federal government regulates the use of controlled substances for legitimate medical, scientific, research, and industrial purposes, and prevents these substances from being diverted for illegal purposes. The CSA assigns various plants, drugs, and chemicals (such as narcotics, stimulants, depressants, hallucinogens, and anabolic steroids) to one of five schedules based on the substance's medical use, potential for abuse, and safety or dependence liability. Schedule I contains substances that have no currently accepted medical use and cannot safely be made available to the public under a prescription, while Schedules II, III, IV, and V include substances that have recognized medical uses and may be manufactured, distributed, and used in accordance with the CSA. The order of the schedules reflects substances that are progressively less dangerous and addictive. To restrict access to chemicals used in the illicit manufacture of certain controlled substances, the CSA also regulates 40 “listed chemicals.†Furthermore, the CSA regulates controlled substance “analogues,†which are substances that are not controlled but are structurally or pharmacologically similar to substances found in Schedule I or II and have no accepted medical use. This is a print on demand report.
Publisher:
ISBN: 9781457842368
Category :
Languages : en
Pages : 20
Book Description
This report highlights certain non-criminal regulatory requirements of the Controlled Substances Act (CSA). The CSA and its implementing regulations establish a framework through which the federal government regulates the use of controlled substances for legitimate medical, scientific, research, and industrial purposes, and prevents these substances from being diverted for illegal purposes. The CSA assigns various plants, drugs, and chemicals (such as narcotics, stimulants, depressants, hallucinogens, and anabolic steroids) to one of five schedules based on the substance's medical use, potential for abuse, and safety or dependence liability. Schedule I contains substances that have no currently accepted medical use and cannot safely be made available to the public under a prescription, while Schedules II, III, IV, and V include substances that have recognized medical uses and may be manufactured, distributed, and used in accordance with the CSA. The order of the schedules reflects substances that are progressively less dangerous and addictive. To restrict access to chemicals used in the illicit manufacture of certain controlled substances, the CSA also regulates 40 “listed chemicals.†Furthermore, the CSA regulates controlled substance “analogues,†which are substances that are not controlled but are structurally or pharmacologically similar to substances found in Schedule I or II and have no accepted medical use. This is a print on demand report.
Guidelines for the Control of Narcotic and Psychotropic Substances
Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241541725
Category : Law
Languages : en
Pages : 144
Book Description
Publisher: World Health Organization
ISBN: 9241541725
Category : Law
Languages : en
Pages : 144
Book Description
Regulating the practice of pharmacy
Author: California
Publisher:
ISBN:
Category : Pharmacy
Languages : en
Pages : 58
Book Description
Publisher:
ISBN:
Category : Pharmacy
Languages : en
Pages : 58
Book Description